2005
DOI: 10.1002/gepi.20133
|View full text |Cite
|
Sign up to set email alerts
|

Incorporating endophenotypes into allele‐sharing based linkage tests

Abstract: For a genetic study in which there are concordant and discordant sibpairs for a complex disease trait and the measurements of other endophenotypes/intermediate phenotypes for each of the individuals are also available, we describe an allele-sharing based multipoint linkage test that utilizes nonparametrically the additional endophenotypes/intermediate phenotypes. The usefulness of this method is evaluated in simulation studies, which show that the gain in power is influenced by not only the endophenotypic valu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…To our knowledge, no study has been conducted to determine the implication of the T323C polymorphism of ET A receptor gene in IR, an intermediate metabolic phenotype for hypertension (43). Thus, we further explored the association of the ET A receptor’s T323C polymorphism with the MetS related quantitative traits.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, no study has been conducted to determine the implication of the T323C polymorphism of ET A receptor gene in IR, an intermediate metabolic phenotype for hypertension (43). Thus, we further explored the association of the ET A receptor’s T323C polymorphism with the MetS related quantitative traits.…”
Section: Discussionmentioning
confidence: 99%
“…It is the latter that we will adhere to in the present report, which typically lay relatively proximal along the genotype-phenotype continuum [Gottesman and Gould, 2003;Almasy and Blangero, 2001]. Such informative latent components provide simpler clues to the genetic underpinnings of clinical phenotypes of the disease, as demonstrated by their recent use in both linkage and association analysis [Pan et al, 2006;Wang et al, 2006]. In studies of complex diseases, various endophenotypes may be extracted from data on physiological challenges, biochemical assays, and physiological measures.…”
Section: Introductionmentioning
confidence: 91%
“…Incorporating EDPs into linkage analyses of complex diseases has been useful in improving power to detect linked loci that were either not detected at all, or that showed much weaker linkage when the clinical disorder was considered alone (Arolt et al, 1999; Freedman et al, 1997; Gasperoni et al, 2003; Ghosh et al, 2003; Greenberg et al, 2000; Hallmayer et al, 2005; Jones et al, 2004; Keating et al, 1991; Keating and Sanguinetti, 2001; Marlow et al, 2003; Matthysse et al, 2004; Spence et al, 2006; Wang et al, 2006; Wilcox et al, 2002). Most of the cited studies considered quantitative EDPs.…”
Section: Introductionmentioning
confidence: 99%